Skip to contentI
InspireMD, Inc.
I
NSPRInspireMD, Inc. Q3 2014 · 10-Q
Revenue$273.00K$273.00K−82.4% vs Q3 2013 Net Income-$6.78M-$6.78MN/M vs Q3 2013 EPS Diluted-$1.96-$1.96N/M vs Q3 2013 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
Operating Cash Flowderived-$5,918,000N/M Free Cash Flowderived-$5,930,000N/M Margins · derivedGross margin-27.8%−79.5 pt vs Q3 2013
Operating margin-2374.0%−2123.7 pt vs Q3 2013
Net margin-2481.7%−2227.5 pt vs Q3 2013
ended Sep 30, 2014 · filed Nov 12, 2014 · 43 d after period end